
    
      All enrolled subjects will receive 1 dose of study vaccine. All subjects will attend formal
      study center visits for safety and immunogenicity assessments on Days 0, 10, 42, 84, and 182
      with a telephone safety contact on Day 364.

      This Protocol Posting has been updated according to Protocol amendment, 8 Dec 08
    
  